Biogen Aktie
142,65
EUR
-0,65
EUR
-0,45
%
151,54
USD
+0,15
USD
+0,10
%
nachbörslich
Biogen Aktie Analyse
09.09.05 | Biogen market perform | Piper Jaffray | |
28.07.05 | Biogen equal-weight | Morgan Stanley | |
17.06.05 | Biogen in-line | Goldman Sachs | |
10.06.05 | Biogen market perform | Piper Jaffray | |
09.06.05 | Biogen in-line | Goldman Sachs | |
03.06.05 | Biogen equal-weight | Morgan Stanley | |
03.06.05 | Biogen Equal-weight | Morgan Stanley | |
03.06.05 | Biogen neutral | UBS | |
Werbung
|
|||
01.06.05 | Biogen neutral | Prudential Financial | |
01.06.05 | Biogen neutral-weight | Prudential Financial | |
28.04.05 | Biogen Hold | Deutsche Securities | |
15.04.05 | Biogen Sector Perform | RBC Capital Markets | |
01.03.05 | Biogen Hold | AG Edwards | |
01.03.05 | Biogen Equal weight | Lehman Brothers | |
01.03.05 | Biogen Hold | Lazard Freres | |
01.03.05 | Biogen Neutral | Prudential Securities | |
01.03.05 | Biogen Market Perform | U.S. Bancorp Piper Jaffray | |
28.02.05 | Biogen Neutral | Credit Suisse First Boston | |
28.02.05 | Biogen Neutral | JP Morgan | |
28.02.05 | Biogen Sector Perform | CIBC World Markets |